IPOPLUS

94.86

-0.22 -0.23%

18 Jun 2026

NSE Listed · Pharmaceuticals

Par Drugs And Chem Ltd. (PAR)

Volume: 5,238Avg Vol 1W: 5,353Avg Vol 1M: 5,27252W Range:78.05122.43
₹94.86 0.23%
Market Cap
Current Price₹94.86
Previous Close₹95.08
High / Low (52w)₹122.43 / ₹78.05
Volume5,238
Avg Vol (1W)5,353
Avg Vol (1M)5,272
Stock P/E7.82
Book Value₹91.04
Dividend Yield
ROE
ROA
Revenue (TTM)
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value₹10
EPS (TTM)₹0.69
P/B1.03
Debt / Equity
50 DMA₹90.31
200 DMA₹97.45
Day change-0.23%
Price Chart
94.86 1.81% · 1Y
182792.4L
2025-06-17
2026-05-11

20-day avg volume: 5K shares

Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020
Revenue₹20 Cr₹29 Cr₹29 Cr₹26 Cr₹22 Cr₹21 Cr₹35 Cr₹23 Cr₹23 Cr₹24 Cr₹26 Cr₹23 Cr₹24 Cr₹23 Cr₹25 Cr₹24 Cr₹22 Cr₹17 Cr₹20 Cr₹16 Cr₹16 Cr₹16 Cr₹17 Cr
EBITDA₹1 Cr₹6 Cr₹6 Cr₹4 Cr₹2 Cr₹1 Cr₹12 Cr₹3 Cr₹5 Cr₹5 Cr₹7 Cr₹3 Cr₹5 Cr₹3 Cr₹5 Cr₹3 Cr₹4 Cr₹3 Cr₹3 Cr₹3 Cr₹4 Cr₹3 Cr₹4 Cr
Net Profit₹1 Cr₹5 Cr₹4 Cr₹3 Cr₹2 Cr₹1 Cr₹9 Cr₹3 Cr₹4 Cr₹3 Cr₹5 Cr₹2 Cr₹3 Cr₹2 Cr₹4 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹2 Cr₹4 Cr
EPS0.693.93.362.71.340.476.992.063.022.783.972.012.81.523.031.861.971.81.823.953.395.7
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹103 Cr₹96 Cr₹96 Cr₹75 Cr₹61 Cr₹56 Cr
EBITDA₹18 Cr₹20 Cr₹15 Cr₹13 Cr₹13 Cr₹7 Cr
Net Profit₹13 Cr₹15 Cr₹11 Cr₹9 Cr₹12 Cr₹5 Cr
EPS10.8611.789.217.4918.877.75
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹119 Cr₹102 Cr₹89 Cr₹79 Cr₹76 Cr₹60 Cr
Total Liabilities₹20 Cr₹16 Cr₹18 Cr₹19 Cr₹24 Cr₹20 Cr
Equity₹99 Cr₹86 Cr₹71 Cr₹60 Cr₹52 Cr₹41 Cr
Total Debt₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹4 Cr₹5 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹21 Cr₹25 Cr₹18 Cr₹11 Cr₹16 Cr
Investing₹-25 Cr₹-6 Cr₹-7 Cr₹-3 Cr₹0 Cr
Financing₹0 Cr₹0 Cr₹0 Cr₹-10 Cr₹2 Cr
Free Cash Flow₹21 Cr₹25 Cr₹18 Cr₹11 Cr₹16 Cr
Shareholding
Promoter 73.41% Institutions 0% Public 26.59%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search